Cover Image

Inflammation Is a Key Pathophysiological Feature of Metabolic Syndrome

Saved in:

Bibliographic Details
Main Authors:	Fabrizio Montecucco (Author), François Mach (Author), Aldo Pende (Author)
Format:	Book
Published:	Hindawi Limited, 2013-01-01T00:00:00Z.
Subjects:	article
Online Access:	Connect to this object online.
Tags:	Add Tag No Tags, Be the first to tag this record!

Similar Items

The Renin-Angiotensin System Modulates Inflammatory Processes in Atherosclerosis: Evidence from Basic Research and Clinical Studies
by: Fabrizio Montecucco, et al.
Published: (2009)

Update on the Pathophysiological Activities of the Cardiac Molecule Cardiotrophin-1 in Obesity
by: Mohamed Asrih, et al.
Published: (2013)

Inflammatory Cardiovascular Risk Biomarkers: Update on Novelties and Limitations
by: Fabrizio Montecucco, et al.
Published: (2012)

Evidence for the Gut Microbiota Short-Chain Fatty Acids as Key Pathophysiological Molecules Improving Diabetes
by: Alessandra Puddu, et al.
Published: (2014)

Role of Mitogen-Activated Protein Kinase Pathways in Multifactorial Adverse Cardiac Remodeling Associated with Metabolic Syndrome
by: Mohamed Asrih, et al.
Published: (2013)

Insulin Resistance: A Proinflammatory State Mediated by Lipid-Induced Signaling Dysfunction and Involved in Atherosclerotic Plaque Instability
by: Fabrizio Montecucco, et al.
Published: (2008)

Role of Matrix Metalloproteinase-8 in Atherosclerosis
by: Sébastien Lenglet, et al.
Published: (2013)

Metabolic syndrome - diagnostics, pathophysiology and treatment
by: Weronika Wasyluk, et al.
Published: (2019)

Metabolic syndrome - diagnostics, pathophysiology and treatment
by: Weronika Wasyluk, et al.
Published: (2019)

Oxidative stress in the pathophysiology of metabolic syndrome: which mechanisms are involved?
by: Thalia M. T. Avelar, et al.
Published: (2015)

An Emerging Role of Glucagon-Like Peptide-1 in Preventing Advanced-Glycation-End-Product-Mediated Damages in Diabetes
by: Alessandra Puddu, et al.
Published: (2013)

Advanced Glycation End Products Play Adverse Proinflammatory Activities in Osteoporosis
by: Roberta Sanguineti, et al.
Published: (2014)

Intraplaque Expression of C-Reactive Protein Predicts Cardiovascular Events in Patients with Severe Atherosclerotic Carotid Artery Stenosis
by: Aldo Bonaventura, et al.
Published: (2016)

Physiology and Pathophysiology of Iron Metabolism
Published: (2023)

Depression and inflammation: Pathophysiology and therapeutic implications
by: Deepti Jangpangi
Published: (2016)

Metabolic Syndrome, Inflammation, and Cancer
by: Yong Wu, et al.
Published: (2017)

Inflammatory Response, a Key Pathophysiological Mechanism of Obesity-Induced Depression
by: Shu-Lin Shao, et al.
Published: (2020)

Update on the Protective Molecular Pathways Improving Pancreatic Beta-Cell Dysfunction
by: Alessandra Puddu, et al.
Published: (2013)

Pathophysiological concepts of the syndrome of chronic fatigue and clinical features as a basis for building physical rehabilitation programs
by: Nadezhda Bogdanovska, et al.
Published: (2016)

Pathophysiological concepts of the syndrome of chronic fatigue and clinical features as a basis for building physical rehabilitation programs
by: Nadezhda Bogdanovska, et al.
Published: (2016)

Statin Treatment Is Associated with Reduction in Serum Levels of Receptor Activator of NF-κB Ligand and Neutrophil Activation in Patients with Severe Carotid Stenosis
by: Sébastien Lenglet, et al.
Published: (2014)

Carbonylated Proteins as Key Regulators in the Progression of Metabolic Syndrome
by: Yuki Kitamura, et al.
Published: (2023)

Aortopathy pathophysiology features in patients with bicuspid aortic valve.
by: Arystan Seidalin, et al.
Published: (2016)

Menstrual migraine - pathophysiology, clinical features and treatment options
by: Dominika Szczotka, et al.
Published: (2024)

The Metabolic Syndrome in Hispanics - The Role of Inflammation
by: Pablo I Altieri, et al.
Published: (2015)

Corrigendum to "Metabolic Syndrome, Inflammation, and Cancer"
by: Yong Wu, et al.
Published: (2017)

Chronic Inflammation in Obesity and the Metabolic Syndrome
by: Rosário Monteiro, et al.
Published: (2010)

Interleukins 4 and 13 in Asthma: Key Pathophysiologic Cytokines and Druggable Molecular Targets
by: Corrado Pelaia, et al.
Published: (2022)

Pathophysiological Role of Extracellular Purinergic Mediators in the Control of Intestinal Inflammation
by: Yosuke Kurashima, et al.
Published: (2015)

Brain Tumour Related Headache: Features, Pathophysiology and Management Strategies
by: Patrycja Doruch, et al.
Published: (2023)

Glucagon-Like Peptide-1 Triggers Protective Pathways in Pancreatic Beta-Cells Exposed to Glycated Serum
by: Alessandra Puddu, et al.
Published: (2013)

Hypopigmented mycosis fungoides: a review of its clinical features and pathophysiology
by: Fabricio Cecanho Furlan, et al.
Published: (2013)

Features of treatment of patients with psoriasis with metabolic syndrome
by: V. R. Khairutdinov, et al.
Published: (2018)

THE FEATURES OF ANTIHYPERTENSIVE THERAPY IN PATIENTS WITH METABOLIC SYNDROME
by: L. V. Kremneva, et al.
Published: (2015)

THE FEATURES OF ANTIHYPERTENSIVE THERAPY IN PATIENTS WITH METABOLIC SYNDROME
by: L. V. Kremneva, et al.
Published: (2015)

A notorious trio! Inflammation, metabolic syndrome and vitiligo
by: Amany I Mustafa, et al.
Published: (2023)

Age-Related Macular Degeneration in the Aspect of Chronic Low-Grade Inflammation (Pathophysiological ParaInflammation)
by: Małgorzata Nita, et al.
Published: (2014)

Metabolic Syndrome in Children: Clinical Picture, Features of Lipid and Carbohydrate Metabolism
by: O.S. Bobrykovych
Published: (2013)

Particular features of lipid metabolism in psoriasis patients with concomitant metabolic syndrome
by: A. G. Pashinyan, et al.
Published: (2017)

A case series of CHARGE syndrome: identification of key features for a neonatal diagnosis
by: Maria Francesca Bedeschi, et al.
Published: (2020)